No Data
No Data
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Beyond The Numbers: 6 Analysts Discuss Catalyst Pharmaceuticals Stock
Catalyst Pharmaceuticals Initiated With an Outperform at Baird
Catalyst Pharmaceuticals Price Target Announced at $28.00/Share by Baird
Catalyst Pharmaceuticals Analyst Ratings